Archangels invests in 3 Edinburgh startups across £15.2m of funding rounds
Archangels participated in 3 UK funding rounds in the last 30 days, leading 1 Seed round and joining 2 Growth/Series A rounds totalling £15.2m.
Archangels was named as a participant in 3 UK funding rounds announced within the last 30 days. The syndicate led 1 of the rounds and participated in the other 2. The three deals disclose a combined £15.2m of capital across seed and growth stages. The financings cover healthtech, fintech and biotech companies.
Recent Activity
Bioliberty raised £7.6m in a growth funding round structured around a £6.1m Series A tranche; the Edinburgh- and Boston-based healthtech company develops the Lifehub platform that combines computer vision, AI and robotics to monitor functional recovery and support post-acute physical and occupational therapy. Archangels was named as a participant in the financing. The company said the funding is earmarked for continued product R&D, US commercial roll-out and the launch of Lifehub Home for remote monitoring.
Earth Blox raised £6m in a growth funding round to expand its team, accelerate product development and enhance its AI-powered nature risk analytics; the Edinburgh-based fintech translates satellite and environmental data into decision-ready insights for businesses and financial institutions. Archangels was named as a participant via follow-on investment. The company said the capital will be used to grow technical and commercial teams and further develop its platform.
BIOCAPTIVA raised £1.6m in a seed funding round to commercialise its patented msX magnetic bead platform for preparing blood samples for liquid biopsy; the University of Edinburgh spin-out says the technology captures cell-free DNA directly from whole blood to simplify sample preparation and enable automation. Archangels led the round. The company said the money will support R&D, expand its product range and drive evidence building and scaling of R&D capability.
What the Recent Deals Show
- Stage distribution: 1 seed round (BIOCAPTIVA) and 2 growth/Series A‑era rounds (Bioliberty, Earth Blox).
- Sector distribution: 1 healthtech, 1 fintech, 1 biotech.
- Geographic mentions: all three articles reference Edinburgh; two deals reference US activity or presence (Bioliberty and BIOCAPTIVA mention Boston and US commercial or research launches).
- Lead investor roles: Archangels led BIOCAPTIVA’s seed round; Bioliberty’s Series A tranche was led by the Scottish National Investment Bank; Earth Blox’s round was led by PXN Ventures.
- Disclosed round size range and total: rounds disclosed range from £1.6m to £7.6m, with combined disclosed capital of £15.2m.
Archangels’ recent named participations span seed to growth stages and three distinct technology sectors, with all three company announcements referencing ties to Edinburgh and two noting activity or launches involving the US.
Click here for a full list of + startup investors in the UK